MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma

MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma

10.1158/1535-7163.MCT-15-0062

Saved in:

Bibliographic Details
Main Authors:	Kong, Li Ren, Chua, Kian Ngiap, Sim, Wen Jing, Ng, Hsien Chun, Bi, Chonglei, Ho, Jingshan, Nga, Min En, Pang, Yin Huei, Ong, Weijie Richard, Soo, Ross Andrew, Huynh, The Hung, Chng, Wee Joo, Thiery, Jean-Paul, Goh, Boon Cher
Other Authors:	BIOMED INST FOR GLOBAL HEALTH RES & TECH
Format:	Article
Language:	English
Published:	American Association for Cancer Research Inc. 2020
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology PLATINUM-BASED CHEMOTHERAPY RANDOMIZED PHASE-III LUNG-CANCER MELANOMA-CELLS MUTATIONS KINASE GROWTH HEAD PROTEIN GENE
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/175514
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.1158/1535-7163.MCT-15-0062